Correlation Between Carmell Therapeutics and Ryanair Holdings

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Carmell Therapeutics and Ryanair Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Carmell Therapeutics and Ryanair Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Carmell Therapeutics and Ryanair Holdings PLC, you can compare the effects of market volatilities on Carmell Therapeutics and Ryanair Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Carmell Therapeutics with a short position of Ryanair Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Carmell Therapeutics and Ryanair Holdings.

Diversification Opportunities for Carmell Therapeutics and Ryanair Holdings

-0.23
  Correlation Coefficient

Very good diversification

The 3 months correlation between Carmell and Ryanair is -0.23. Overlapping area represents the amount of risk that can be diversified away by holding Carmell Therapeutics and Ryanair Holdings PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ryanair Holdings PLC and Carmell Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Carmell Therapeutics are associated (or correlated) with Ryanair Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ryanair Holdings PLC has no effect on the direction of Carmell Therapeutics i.e., Carmell Therapeutics and Ryanair Holdings go up and down completely randomly.

Pair Corralation between Carmell Therapeutics and Ryanair Holdings

Assuming the 90 days horizon Carmell Therapeutics is expected to under-perform the Ryanair Holdings. In addition to that, Carmell Therapeutics is 18.95 times more volatile than Ryanair Holdings PLC. It trades about -0.3 of its total potential returns per unit of risk. Ryanair Holdings PLC is currently generating about 0.07 per unit of volatility. If you would invest  4,458  in Ryanair Holdings PLC on September 14, 2024 and sell it today you would earn a total of  99.00  from holding Ryanair Holdings PLC or generate 2.22% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy38.1%
ValuesDaily Returns

Carmell Therapeutics  vs.  Ryanair Holdings PLC

 Performance 
       Timeline  
Carmell Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Carmell Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.
Ryanair Holdings PLC 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Ryanair Holdings PLC are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, Ryanair Holdings may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Carmell Therapeutics and Ryanair Holdings Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Carmell Therapeutics and Ryanair Holdings

The main advantage of trading using opposite Carmell Therapeutics and Ryanair Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Carmell Therapeutics position performs unexpectedly, Ryanair Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ryanair Holdings will offset losses from the drop in Ryanair Holdings' long position.
The idea behind Carmell Therapeutics and Ryanair Holdings PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities